Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Priority review for Gaucher drug

December 12, 2013 Sales and Marketing EMA, FDA, Gaucher, Genzyme, Sanofi

The FDA is to conduct a speedy investigation into Sanofi’s twice-daily oral candidate for Gaucher disease, which means that Cerdelga …
News

ABPI appoints nightclub owner as new NHS manager

December 12, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, nightclub, tugnet

The ABPI has appointed Raj Tugnet as its new NHS partnership manager to lead ABPI activities on academic health science …
Appointment

Novo Nordisk faces police probe

December 11, 2013 Medical Communications, Sales and Marketing FDA, Novo Nordisk, police

Novo Nordisk is facing an investigation from Denmark’s police over delaying the release of negative information it received from the …
News

UK government doubles dementia funding

December 11, 2013 Research and Development, Sales and Marketing Alzheimer's, Cameron, Merck, Obama, dementia

UK prime minister David Cameron has announced that the government is to increase funding research into dementia, spending £52 million …
News

Twitter ‘drama’ produces drubbing for Medivir

December 11, 2013 Medical Communications, Sales and Marketing Medivir, Twitter, digital, nasdaq

A NASDAQ disciplinary committee has found Medivir guilty of breaching its rules after data from a trial was posted on …
News

AbbVie posts strong results for Hep C pill

December 11, 2013 Research and Development, Sales and Marketing 3D, AbbVie, FDA, Gilead, hep C

AbbVie’s investigational hepatitis C pill cured 96% of difficult-to-treat patients in a late-stage clinical trial and looks set to muscle …
News

Mike Nally replaces Deepak Khanna as MSD head

December 11, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, mike nally

Merck Sharp & Dohme has confirmed that Mike Nally will succeed Deepak Khanna as managing director for MSD in the …
Appointment

PIP founder jailed for fraud

December 11, 2013 Medical Communications, Sales and Marketing breast, implants, pip, silicone

The boss of a French firm at the centre of a global health scare over faulty breast implants has been …
News

Cancer diagnosis is ‘national disgrace’

December 10, 2013 Sales and Marketing CCGs, Cancer, NHS, appgc

Cancer care is still dangerously dependent on where patients in England live according to an influential group of MPs and …
News

Wii Fit Plus benefits patients with diabetes

December 10, 2013 Medical Communications, Sales and Marketing bmc, diabetes, games, type 2, wii fit plus

A study says using interactive games through Nintendo’s Wii console helped type 2 diabetics to control their disease and improve …
News

J&J chooses UK as a new hub to ‘listen’ for innovation

December 10, 2013 Research and Development, Sales and Marketing J&J, JJ, UK, innovation, research

Johnson & Johnson has chosen the UK as its formal European hub after announcing the creation of five new sites …
News

Nuevolution hires Takeda head as chief business officer

December 10, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, neuvolution

Small molecule lead discovery firm Nuevolution has poached Ton Berkien from Takeda to join the firm as a chief business …
Appointment

Cancer Research: ‘Advert helped early diagnosis’

December 10, 2013 Medical Communications, Sales and Marketing Cancer, be clear, cough, government

A TV campaign urging people with a persistent cough to visit their doctor has led to hundreds of people receiving …
News

CLL drug achieves ‘unprecedented’ remissions

December 9, 2013 Research and Development, Sales and Marketing AbbVie, CML, Genentech, abt-199

AbbVie and Genentech’s investigational oncology drug ABT-199 has performed well in a Phase I trial for blood cancer, according to …
News

Gilead’s $1,000 per day Hep C drug approved

December 9, 2013 Sales and Marketing FDA, Gilead, hepc, sofosbuvir, sovaldi

Gilead’s Sovaldi has gained FDA approval as a potential cure for hepatitis C after the US regulator sped up its …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026